Table 3

Predictors of in-hospital mortality and overall postdischarge mortality in Medicare beneficiaries hospitalised for CLD in 2005–2010*

PredictorsIn-hospital mortalityPostdischarge mortality†
OR (95% CI)OR (95% CI)
Age
 65–69RefRef
 <650.83 (0.69 to 0.99)0.83 (0.72 to 0.94)
 70–741.06 (0.85 to 1.31)1.16 (0.99 to 1.35)
 75–791.28 (1.03 to 1.60)1.33 (1.13 to 1.56)
 80–840.91 (0.71 to 1.18)1.23 (1.04 to 1.46)
 85 and over0.92 (0.70 to 1.21)1.51 (1.27 to 1.80)
Gender
 FemaleRefRef
 Male1.27 (1.11 to 1.44)1.34 (1.22 to 1.46)
Race
 WhiteRefRef
 Black1.18 (0.96 to 1.44)0.81 (0.70 to 0.95)
 Hispanic0.74 (0.52 to 1.04)0.91 (0.73 to 1.13)
 Other1.11 (0.82 to 1.51)0.79 (0.63 to 0.99)
ESRD
 NoRefRef
 Yes0.73 (0.55 to 0.98)1.14 (0.93 to 1.40)
Number of admissions
 1RefRef
 ≥21.50 (1.31 to 1.73)1.62 (1.46 to 1.80)
Discharge destination
 HomeNARef
 Continued careNA2.51 (2.29 to 2.76)
 HospiceNA44.98 (33.0161.28)
Region
 NortheastRefRef
 South0.95 (0.81 to 1.13)1.27 (1.12 to 1.43)
 Midwest0.79 (0.65 to 0.96)1.10 (0.96 to 1.26)
 West0.84 (0.65 to 1.10)1.33 (1.11 to 1.60)
 California0.95 (0.74 to 1.22)1.23 (1.02 to 1.47)
Calendar year0.90 (0.87 to 0.94)1.00 (0.98 to 1.03)
Number of diagnosis1.24 (1.17 to 1.32)1.06 (1.03 to 1.09)
Number of procedures1.36 (1.31 to 1.41)0.98 (0.96 to 1.01)
Charlson score1.01 (0.98 to 1.05)1.24 (1.21 to 1.28)
LOS1.01 (1.00 to 1.02)1.02 (1.01 to 1.03)
  • *Data in 2008 were excluded from analysis due to missing information on patient's residence region.

  • †Patients were followed up to March of the year following the hospitalisation.

  • CLD, chronic liver disease; ESRD, end-stage renal disease; LOS, length of stay; NA, not applicable.